melflufen

Known as: melphalan-flufenamide 
 

Topic mentions per year

Topic mentions per year

2013-2017
012320132017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Aminopeptidases like aminopeptidase N (APN, also known as CD13) play an important role not only in normal cellular functioning… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2017
2017
The novel aminopeptidase potentiated alkylating agent melflufen, was evaluated for activity in acute myeloid leukemia in a range… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2017
Review
2017
INTRODUCTION Multiple myeloma (MM) is a hematologic malignancy characterized by proliferation of malignant plasma cells. patient… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2016
2016
Ovarian cancer carries a significant mortality. Since symptoms tend to be minimal, the disease is often diagnosed when peritoneal… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2016
2016
Our prior study utilized both in vitro and in vivo multiple myeloma (MM) xenograft models to show that a novel alkylator… (More)
Is this relevant?
2016
2016
Melphalan has been used in the treatment of various hematologic malignancies for almost 60 years. Today it is part of standard… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2016
2016
Delforoush, M. 2016. Potential New Drugs in Lymphoma. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
2015
2015
Purpose Melflufen (melphalan flufenamide, previously designated J1) is an optimized and targeted derivative of melphalan… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2013
2013
Aminopeptidase N (APN) has been reported to have a functional role in tumor angiogenesis and repeatedly reported to be over… (More)
Is this relevant?